Psychedelics Emory University measures psilocybin therapy healing with voice analysis app 'Fabla' was developed by tech geeks from Emory's AppHatchery team Rowan DunneMarch 28, 2025
Psychedelics Taking psilocybin or LSD can lessen frequency of severe headaches by 25% A study published in the Journal of Psychopharmacology last week yielded this finding Rowan DunneMarch 20, 2025
Medical and Pharmaceutical NRx Pharmaceuticals submits NDA for intravenous ketamine drug This therapeutic is specifically designed for suicidal depression Rowan DunneMarch 19, 2025
Psychedelics Intranasal delivery tech developer ‘Polyrizon’ plans to administer psychedelics The Israeli company has an unnamed new partner involved with unspecified psychedelic drugs Rowan DunneMarch 18, 2025
Psychedelics Mescaline drug developer Neural Therapeutics closes funding needed for CSE listing This company's primary focus is making an extract from San Pedro -- a psychedelic cactus Rowan DunneMarch 14, 2025
Psychedelics Psilocybin shows great promise for brain recovery after head injuries in rodents These findings are reinforced by the growing popularity of psychedelics among athletes who have had multiple concussions Rowan DunneMarch 6, 2025
Psychedelics Colorado students interested in psychedelics gain access to US$1.5M grant Those enrolling at Naropa University who want to do a minor in psychedelics now have more incentive Rowan DunneMarch 4, 2025
Psychedelics Synthetic ibogaine: a game changer for mental health treatment Scientists at UC Davis are making a short supply of the African iboga shrub a less significant problem Rowan DunneFebruary 13, 2025
Psychedelics 51 Colorado residents become state’s first certified magic mushroom therapists They recently graduated from a psychedelic therapy facilitator program run by InnerTrek Rowan DunneFebruary 12, 2025
Psychedelics ‘Snowball Cubensis’ psilocybin strain turns heads, completely unique The world has never seen anything quite like this Rowan DunneFebruary 7, 2025